Diagnostic Value of Temporal Muscle Ultrasound Parameters in the Assessment of Pediatric Malnutrition: A Prospective Observational Study
Journal of Clinical Ultrasound · 2026-11 · 54 (9) · 2121-2130
DOI: 10.1002/jcu.70320 ↗Abstract
ABSTRACT Objectives The primary focus of this study was to compare the diagnostic accuracy of temporal muscle (TM) B‐mode ultrasound and shear wave elastography (SWE) parameters in the assessment of pediatric and to establish practical cutoff values for clinical use. Methods This prospective observational study included a total of 89 children aged 5–18 years, consisting of 35 primary malnourished patients and 54 healthy controls. TM thickness, total tissue thickness (muscle and subcutaneous fat), tissue stiffness, and shear wave speed were measured in the temporal fossae using a high‐frequency linear transducer. For SWE quality standardization, Motion Stability (M‐STB) and Reliability (RLB) indices were actively utilized. The obtained data were modeled using multivariate logistic regression, Decision Curve Analysis (DCA), and receiver operating characteristic (ROC) curves. Results All investigated ultrasonographic and biomechanical values were significantly lower in the malnutrition group compared to controls ( p < 0.001). In the multivariate logistic regression analysis, which was adjusted to resolve multicollinearity (VIF > 20) among the SWE parameters, TM thickness emerged as the strongest independent predictor of malnutrition (OR = 0.428, p < 0.001). ROC analyses demonstrated that TM thickness yielded the highest diagnostic accuracy (AUC = 0.887). A cut‐off value of approximately 11.15 mm for this parameter provided a sensitivity of 82.9% and specificity of 90.7%. The DeLong test results confirmed that the discriminatory power of TM thickness was statistically superior to that of the elastography data. Conclusions TM thickness measurement via B‐mode ultrasound is a practical, reproducible, and promising adjunctive point‐of‐care parameter for detecting malnutrition‐induced muscle atrophy in pediatric patients, demonstrating superiority over SWE parameters; however, external multicenter validation is warranted before routine clinical implementation.
EUVIMED